On February 28th 2019, Quality Cancer Care Alliance(QCCA) held its winter leadership conference in Phoenix, Arizona. Representatives from 29 practices across the United States attended the summit to learn and participate about the cancer care landscape, new innovative therapies and upcoming initiatives to improve cancer care. Among the attendees were several providers and leaders from Northwest Medical Specialties, PLLC including Sibel Blau, MD; Robert McCroskey, MD; Swathi Namburi, MD; Ndegwa Njuguna, MD; Rohan Sharma, MD.
Sibel Blau, MD, president of QCCA opened the meeting with an overview of where the healthcare landscape is now and where its heading. This kick-off presentation set the tone for the meeting as many speakers followed after to bring insight and knowledge to the rest in attendance. Speakers including Barbara L. McAneny, MD, FASCO, MACP; Ted Okon, Executive Director, COA; Ray Page, DO, PhD, The Center for Cancer and Blood Disorders; Ed Rodgers, VIA Oncology; Robert Carlson, MD, Chief Executive Officer, NCCN; Ken Anderson, MD, Program Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics, Dana Farber Cancer Institute.
QCCA strives to improve the quality of care by marshaling the most effective therapies, diagnostics, processes, and research in the service of our patients. Cancer care is best delivered locally, in the patient’s own community, by independent practitioners who provide personal, yet technologically advanced care. Our efforts are primarily focused on helping our member practices flourish by providing them with the best business models, practice efficiencies, and financial advantages.
